The comprehensive preclinical toxicology evaluation is a critical step in the antipsychotic drug development process. This involves a series of experiments and analyses to assess the safety and potential toxicity risks of a drug. Ace Therapeutics offers a comprehensive antipsychotic preclinical toxicology evaluation service designed to provide drug developers with comprehensive toxicology data to help accelerate their drug development programs.
The development of antipsychotics has revolutionized the practice of psychiatry. However, these drugs can cause severe toxicity after overdose, which is common in patients with psychiatric disorders. They have also been associated with many adverse effects, mainly involving the cardiovascular, endocrine, and neurological systems. Toxicologic studies of antipsychotic drugs can be used to assess the negative effects and side effects that these drugs may cause in the treatment of psychiatric disorders. Furthermore, toxicology studies of these medications assist physicians in understanding the safety and efficacy of the medications, thereby enabling them to provide more effective treatment options for their patients.
Our comprehensive toxicology testing services are tailored by experienced toxicologists to meet the specific needs of our clients.
Acute and Chronic Toxicity Assessment of Antipsychotics
The acute toxicity test we provide is designed to evaluate the acute toxicity reaction after drug administration. This includes the observation of changes in the behavior and signs of the animals, as well as the toxic effects of the drug on different organs. In contrast, the chronic toxicity test assesses the long-term toxicity of the drug to different organs by continuously administering the drug for a defined period and monitoring the pathological and physiological changes in the animals under the influence of the drug.
Organ Toxicity Assessment of Antipsychotics
We utilize animal models to assess the potential acute and chronic toxicity of our antipsychotic candidates to the central nervous system, cardiovascular system, endocrine system, and other vital organs. This helps our clients obtain comprehensive drug safety data.
Developmental & Reproductive Toxicologic Assessment of Antipsychotics
We conduct comprehensive analyses of the developmental and reproductive toxicity of antipsychotic candidates through cellular and animal models. This may include assessing the effects of drug candidates on the reproductive system and embryonic development, effects on fertility, and effects on the health of the offspring.
Genotoxic Assessment of Antipsychotics
We assist our clients in comprehensively assessing the potential genotoxic effects of antipsychotic candidates, as well as their impact on genetic material and genetic stability, through a series of validated tests.
Carcinogenicity Assessment of Antipsychotics
Our approach involves exposing rodents to candidates and utilizing advanced techniques to identify and quantify the potential cancer risk associated with antipsychotic candidates. Our bespoke experimental designs and dependable data analysis services guarantee the delivery of accurate data, enabling you to assess the safety of your antipsychotic drug candidates with confidence.
Ace Therapeutics is committed to providing pharmaceutical and biotechnology companies with comprehensive toxicology evaluation services to help accelerate the development of antipsychotic drugs. Please do not hesitate to contact us for further information and assistance.
Enter your E-mail and receive the latest news from us